"/> Novus Biologicals™ Peptide bloquant d’anticorps KL… | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps KLRA1

Réf. : BL-RE-083949Réf. fabricant : 18220026 0.05 mg
201,94 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
10748
Espèces
Human
Contenu et stockage
Store at -20 C. Avoid freeze-thaw cycles.
Formule
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)
This Peptide is Useful as a Blocking Peptide for NBP1-77343. For Further Blocking Peptide Related Protocol, Click Here .
Marque
Novus Biologicals

A blocking peptide containing 13 amino acids near the center of human KLRA1.

Points forts

Source

Synthetic

(Accession #: EAW96194) The KLRA1 Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-083949
Réf. fabricant18220026
Gene ID (Entrez)10748
EspècesHuman
Contenu et stockageStore at -20 C. Avoid freeze-thaw cycles.
FormulePBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NBP1-77343. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gènekiller cell lectin-like receptor subfamily A pseudogene 1, KLRA#, KLRA1, Ly49, Ly-49 L, LY49L, MGC126520, MGC126522
Symbole de gène(s)KLRA1P
Type de produitKLRA1
Quantité0.05 mg
État réglementaireRUO - research use only
SourceSynthetic
Consigne13 amino acids near the center of human KLRA1
Une question, une configuration particulière ?
Contactez-nous pour un devis.